Results 161 to 170 of about 49,940 (198)
Some of the next articles are maybe not open access.
Re-challenge with Etanercept in patients with Etanercept-induced Neutropenia
Clinical Rheumatology, 2011TNF blockers have rarely been associated with haematological complications; however, there are scattered case reports of marked neutropenia with their use and necessitating in their withdrawal. We would like to report a series of five patients who developed neutropenia with etanercept use; however, all these patients were re-challenged with etanercept ...
Haroon, Muhammad +2 more
openaire +3 more sources
Expert Opinion on Pharmacotherapy, 2004
Psoriasis is a chronic skin disorder that affects approximately 2% of the US and European populations. Several lines of evidence have demonstrated the correlation between elevated levels of TNF and psoriasis, suggesting that interfering with the inflammatory effects of TNF may help resolve psoriatic lesions. The biological agent, etanercept, is a fully
openaire +2 more sources
Psoriasis is a chronic skin disorder that affects approximately 2% of the US and European populations. Several lines of evidence have demonstrated the correlation between elevated levels of TNF and psoriasis, suggesting that interfering with the inflammatory effects of TNF may help resolve psoriatic lesions. The biological agent, etanercept, is a fully
openaire +2 more sources